Felpreva (1 - 2.5 kg)
Active substance
ATC code
Species
Cats.
Indications
For cats with, or at risk from, mixed parasitic infestations/infections. The veterinary medicinal product is exclusively indicated when ectoparasites, cestodes and nematodes are targeted at the same time.
Ectoparasites
• For the treatment of flea (Ctenocephalides felis) and tick (Ixodes ricinus, Ixodes holocyclus) infestations in cats providing immediate and persistent killing activity for 13 weeks.
• The veterinary medicinal product can be used as part of a treatment strategy for the control of flea allergy dermatitis (FAD).
• For the treatment of mild to moderate cases of notoedric mange (Notoedres cati).
• For the treatment of ear mite infestations (Otodectes cynotis)
Gastrointestinal roundworms (nematodes)
For the treatment of infections with:
• Toxocara cati (mature adult, immature adult, L4 and L3)
• Toxascaris leonina (mature adult, immature adult and L4)
• Ancylostoma tubaeforme (mature adult, immature adult and L4)
Lungworms (nematodes)
For the treatment of infections with:
• Aelurostrongylus abstrusus (adult)
• Troglostrongylus brevior (adult)
Tapeworms (cestodes)
For the treatment of tapeworm infections:
• Dipylidium caninum (mature adult and immature adult)
• Taenia taeniaeformis (adult)
Dose to be administered and administration route
Spot-on use. For external use only.
Posology
The recommended minimum doses are 14.4 mg tigolaner / kg body weight, 3 mg emodepside / kg body weight, 12 mg praziquantel / kg body weight equivalent to 0.148 ml product / kg body weight.
|
Body Weight of Cat (kg) |
Applicator size to be used: Felpreva spot-on solution |
Volume of unit (ml) |
Tigolaner (mg/kg bw) |
Emodepside (mg/kg bw) |
Praziquantel (mg/kg bw) |
|
1.0 - 2.5 |
for small cats |
0.37 |
14.5 – 36.2 |
3.0 - 7.5 |
12.0 – 30.1 |
|
2.6 - 5.0 |
for medium cats |
0.74 |
14.5 – 27.9 |
3.0 – 5.8 |
12.0 – 23.2 |
|
5.1 - 8.0 |
for large cats |
1.18 |
14.4 – 22.7 |
3.0 - 4.7 |
12.0 - 18.8 |
|
> 8.0 |
Use an appropriate combination of applicators |
||||
Treatment schedule
Treatment is only indicated when ectoparasites, cestodes and nematodes are targeted at the same time. In the absence of mixed infections or risk of mixed infections, appropriate narrow spectrum antiparasitic products should be used.
Fleas and ticks
The veterinary medicinal product remains active against fleas and ticks for a period of 13 weeks.
If re-treatment is necessary within 13 weeks after administration, an appropriate narrow-spectrum product should be used.
Mites
For the treatment of ear mites (Otodectes cynotis) and notoedric mange (Notoedres cati) a single dose of the veterinary medicinal product should be administered. The treatment success and the need for re-treatment with an appropriate narrowspectrum antiparasitic product should be determined by the treating veterinarian after 4 weeks.
Due to individual cases of single surviving ear mites and, therefore, the risk of a new cycle of otocariosis, the treatment success should be confirmed by the veterinarian 1 month after treatment.
Gastrointestinal nematodes and tapeworms
For the treatment of roundworms and tapeworms a single dose of the veterinary medicinal product should be administered. The need for and frequency of retreatment should be in accordance with the advice of the prescribing veterinarian and take into account the local epidemiological situation as well as the cat’s lifestyle. If a re-treatment is necessary within 3 months after administration, an appropriate narrow-spectrum product should be used.
Lungworms
For treatment against the lungworm Aelurostrongylus abstrusus and Troglostrongylus brevior, one treatment with the product followed by a second treatment two weeks apart with a spot-on solution for cats containing 21.4 mg/ml emodepside and 85.8 mg/ml praziquantel is recommended as there is no veterinary medicinal product containing only emodepside as active substance.
Method of administration
Use scissors (1) to open the childproof blister. Pull foils apart (2) and remove spot-on applicator from package (3).
Hold applicator in upright position (4), twist and pull off cap (5) and use the opposite end of the cap to break the seal (6).
Part the fur on the cat’s neck at the base of the skull until the skin is visible (7). Place the tip of the applicator on the skin and squeeze firmly several times to empty the contents directly onto the skin (7). Application on the base of the skull will minimise the ability of the cat to lick the product off.
Adverse reactions
Mild and transient application site reactions following administration such as scratching, erythema, thinning of hair and/or inflammation may occur in very rare cases. Cosmetic effects such as a temporary spiking of the hair at the application site are commonly observed.
Neurological disorders such as ataxia and tremor may occur in very rare cases.
Mild and transient digestive tract disorders such as hypersalivation or vomiting may occur in very rare cases. These effects are thought to occur as a result of the cat licking the application site immediately after treatment. In individual cases these signs can be accompanied by non-specific signs such as agitation, vocalisation or inappetence.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
| PRICE | Only for registered vets. Create a free profile to access all features.. Login |
|---|---|
| Art. Nr. | 06462/5016 |
| EAN | 3605874635289 |
